Company signals · MedTech
HistoSonics
1 signal in the current window, with MitchelLake's leadership read on each.
Market context: Against a Talent Market Index of 98.6 (Neutral) (down 1.4 month-on-month), Asia is at rising (+2.4pts) on signal share.
HistoSonics: 1 signal in the last 90 days — in line with the MedTech median of 1 across 18 tracked companies; 0.1% of MitchelLake's Asia signal flow.
Signals at HistoSonics
More signals across MedTech
Geographic Expansion · Asia
Stryker →Stryker has established APAC operations with dedicated VP and General Manager role, indicating significant regional investment in medical technologies
Partnership · Asia
ZEISS Medical Technology →ZEISS Medical Technology signed a strategic agreement with Aier Eye Hospital Group for purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers across multiple locations
Geographic Expansion · Oceania
Dedalus →Dedalus is expanding its diagnostic imaging portfolio into Australia and has appointed a senior business lead to drive the initiative
Product Launch · EMEA
Abbott →Abbott launched CE-marked dual glucose-ketone Libre Duo sensors in Europe through expanded partnership with MiniMed, representing first-of-its-kind dual-analyte diabetes technology
Partnership · EMEA
Cepheid →Cepheid launched landmark 30-month study with the Fleming Initiative at London NHS Trusts to evaluate rapid CPE screening for drug-resistant infections
Ma Activity · EMEA
Medtronic →Medtronic completed its acquisition of Scientia Vascular, integrating neurovascular access and therapeutic portfolios.
Intelligence powered by Autonodal ↗